2012 Clinical Issues in HIV Medicine: Commemorating AIDS 2012

A PDF reader is required to view this content.

 Introduction

 Authors: Kenneth H. Mayer and Daniel R. Kuritzkes

---

pp. 3 -10

Immunologic Criteria Are Poor Predictors of Virologic Outcome: Implications for HIV Treatment Monitoring in Resource-Limited Settings

Authors: Rawizza et al

---

pp. 11-20

Improved Virological Outcome in White Patients Infected With HIV-1 Non-B Subtypes Compared to Subtype B

Authors: Scherrer et al

---

pp. 21-23

Editorial Commentary: Antiretroviral Therapy for HIV: Do Subtypes Matter?

Authors: JM Gatell

---

pp. 24-33

AIDS and Non-AIDS Morbidity and Mortality Across the Spectrum of CD4 Cell Counts in HIV-Infected Adults Before Starting Antiretroviral Therapy in Côte d’Ivoire

Authors: Anglaret et al

---

pp. 34-43

Paradoxical Immune Reconstitution Inflammatory Syndrome in HIV-Infected Patients Treated With Combination Antiretroviral Therapy After AIDS-Defining Opportunistic Infection

Authors: Achenback et al

---

pp. 44-57

A Review of the Virological Efficacy of the 4 World Health Organization–Recommended Tenofovir-Containing Regimens for Initial HIV Therapy

Authors: Tang et al

---

pp. 58-59

Editorial Commentary: Least Among Equals

Authors: Kuritzkes et al

---

pp. 60-70

Abacavir/Lamivudine Versus Tenofovir DF/Emtricitabine as Part of Combination Regimens for Initial Treatment of HIV: Final Results

Authors: Sax PE et al

---

pp. 71-73

Editorial Commentary: Optimizing Initial Therapy for HIV Infection

 Authors: Hull MW et al

---

pp. 74-79

Viremia and HIV-1 Drug Resistance Mutations among Patients receiving Second-line HAART in Chennai, South India

Authors: Saravanan, Shanmugam

---

pp. 80-88

Increased Risk of Preterm Delivery Among HIV-Infected Women Randomized to Protease Versus Nucleoside Reverse Transcriptase Inhibitor-Based HAART During Pregnancy

Authors: Powis K et al

---

pp. 89-90

Antiretroviral Use During Pregnancy and Risk of Preterm Delivery: More Questions Than Answers

Authors: Kourtis AM et al

---

pp. 91-101

Bone Mineral Density and Fractures in Antiretroviral-Naive Persons Randomized to Receive Abacavir-Lamivudine or Tenofovir Disoproxil Fumarate-Emtricitabine Along With Efavirenz or Atazanavir-Ritonavir: AIDS Clinical Trials Group A5224s, a Substudy of ACTG A5202

Authors: McComsey GA et al

---

pp.102-104

Editorial Commentary: Increasing Clarity on Bone Loss Associated With Antiretroviral Initiation

Authors:Yin MT et al

---

pp. 105-113

 Efficacy and Safety of Once-Daily Nevirapine- or Efavirenz-Based Antiretroviral Therapy in HIV-Associated Tuberculosis: A Randomized Clinical Trial

Authors: Swaminathan et al

---

pp. 114-122

Hepatitis B Virus Coinfection Negatively Impacts HIV Outcomes in HIV Seroconverters

Authors: Chun HM et al

---

pp. 123-125

Preventing Deaths in Persons With HIV/Hepatitis B Virus Coinfection: A Call to Accelerate Prevention and Treatment Efforts

Authors: Peters PJ et al

---

pp. 126-133

HIV-infected Ugandan adults taking ART with CD4 counts > 200 cells/µL who discontinue cotrimoxazole prophylaxis have increased risk of malaria and diarrhea

Authors: Campbell, James

---

pp. 134-142

Neurocognitive and motor deficits in HIV-infected Ugandan children with high CD4 cell counts

Authors: Ruel, Theodore

---

pp. 143-145

Editorial Commentary: Yet another reason to treat HIV infection

Authors: Wagner, Thor

---

pp. 146-155

 Higher Antigen Content Improves the Immune Response to 2009 H1N1 Influenza Vaccine in HIV-Infected Adults: A Randomized Clinical Trial. 

Authors: Hana M et al

---

pp. 156-158

 Editorial Commentary: Sometimes more is better

Authors: Overton T

---

pp. 159-166

Determinants of Per-Coital-Act HIV-1 Infectivity Among African HIV-1–Serodiscordant Couples

Authors: Hughes J et al

---

pp. 167-168

Editorial Commentary: Probability of Heterosexual HIV-1 Transmission per Coital Act in Sub-Saharan Africa

Authors: Gray R et al

---

pp. 169-177

Analysis of Genetic Linkage of HIV From Couples Enrolled in the HIV Prevention Trials Network 052 Trial

Authors: Eshleman S et al

---

pp. 178-183

High-dose Valacyclovir HSV-2 Suppression Results in Greater Reduction in Plasma HIV-1 Levels Compared With Standard Dose Acyclovir Among HIV-1/HSV-2 Coinfected Persons: A Randomized, Crossover Trial

Authors: Mugwanya K et al

---

pp. 184-188

Editorial Commentary: Time to Refocus on HSV Interventions for HIV Prevention?

Authors: Tanton C et al

---

pp. 189-195

What Is the Impact of Home-Based HIV Counseling and Testing on the Clinical Status of Newly Enrolled Adults in a Large HIV Care Program in Western Kenya?

Authors: Wachira et al

---

pp. 196-198

Editorial Commentary: Home-Based HIV Counseling and Testing as a Gateway to Earlier Initiation of Antiretroviral Therapy

Authors: Mills and Ford

---

pp. 199

Public Health Implications for Adequate Transitional Care for HIV-Infected Prisoners: Five Essential Components

Authors:Springer et al

 

 

Printing of the 2012 edition was supported by an unrestricted grant from the Prevention IS Care campaign.